Abstract

Positron emission tomography (PET) radioligands targeting the human translocator membrane protein (TSPO) are broadly used for the investigations of neuroinflammatory conditions associated with neurological disorders. Structural information on the mammalian protein homodimers—the suggested functional state of the protein—is limited to a solid-state nuclear magnetic resonance (NMR) study and to a model based on the previously-deposited solution NMR structure of the monomeric mouse protein. Computational studies performed here suggest that the NMR-solved structure in the presence of detergents is not prone to dimer formation and is furthermore unstable in its native membrane environment. We, therefore, propose a new model of the functionally-relevant dimeric form of the mouse protein, based on a prokaryotic homologue. The model, fully consistent with solid-state NMR data, is very different from the previous predictions. Hence, it provides, for the first time, structural insights into this pharmaceutically-important target which are fully consistent with experimental data.

Highlights

  • The mTSPO_NMR model (Figure 2A) reveals some drawbacks: (i) Residues N92, W93, W95, I98, F100, G101, and A102, experimentally identified to be located at the monomer-monomer interface, are separated by a distance of 9 Å or more (Table 1 and Figure 2A); (ii) there are six residues, from F74 to M79, located at the dimer interface, that were found elsewhere experimentally (Table 1 and Figure 2A); (iii) The predicted embedding of the protein into the membrane shows that the dimer is significantly tilted with respect to the membrane plane

  • We underline that the embedding in the mitochondria membrane is compatible with the generalized membrane used by the Positioning of Proteins in Membranes (PPM) server

  • The PPM database contains the monomer of mouse translocator membrane protein (TSPO) embedded in mitochondria membrane and either the tilt and membrane thickness is fully compatible with our modeled structure (Figure 2E); (iv) Several charged residues are exposed towards the membrane; (v) PK11195 forms highly stabilizing interactions in the Bacillus cereus TSPO/PK11195 X-ray structure (PDBiD: 4RYI) (these are π-stacking interactions with F90 and hydrogen bonds (H-bonds) with W51 (Figure S2B,C)) [36], not present in this model

Read more

Summary

Introduction

CCuurrrreenntt iinnffoorrmmaattiioonn oonn ththeestsrturcutcutruarlaldedteetremrminiannatns tsanadndthethseubsuunbiut-nsiut-bsuunbiut naitsseamssbelmybolyf mofammmamalmiaanliTaSnPOTSsPiOs ds eirsivdederfirvoemd sfroolimd-sstoatliedN-sMtatRe inNvMesRtigiantvioenstsigoantitohnesmoonusteheprmotoeuinse(mpTrSoPteOin) [(2m0T].STPhOis) i[s2e0x]p. eTctheids tios beexpsiemctieladr ttoo tbhee hsiummilaanr TtoSPtOhe, bheucamuasne oTfStPhOe h, ibgehcamuusteuaolf stehqeuehnigche imdeunttuitayl (s8e1q%ue, nacse oibdteanintietdy f(r8o1m%, thaes aonbatlayisniesdoffrtohme stehqeueanncaelyisdisenotiftythpeersfeoqrmueendcewiitdhenBtLitAy SpTer[f2o1r,m22e])d. mwiTthSPBOL’sAmSTon[2o1m,2e2r]-)m. omnoTmSPeOr ’isntmerofancoeminevr-omlvoensormeseirduinetserfrfaocme tinhevoTlvMe-sIIrIehsiedliuxe[s20fr]o(mFigtuhereT1Ma-nIIdI Thaeblilxe [12)0. ]Th(Feisgeuirnecl1udaen:d(i)TathbeleG18).XXTXhGes8e7 i(nXcl=uadney: r(ei)sidthuee)Gm83oXtiXf XprGe8se7n(tXac=roassnydirffeesriednutep) rmotoetinif cplraessseens’t ianctreorsfascdesif,fe[2re3n–2t 7p];roatnedin (ciil)astshees’Win9t5eXrfPaXceFs9,8[2m3o–t2i7f];[2a8n],do(ciciu) rtrhinegWa9c5roXsPsXeFu9k8armyoottiicf [a2n8d], porcocukarrriynogticacTrSoPsOs se. uInkatrhyeotsiacmaensdtudpyro, kthareyaoutitchoTrSs PaOlsso. preInsenttheed saapmreedsictutidony, otfhteheafuutnhcotrisonaallslyo rperleesveanntteddima epr rsetdruiccttiuorne, obfastehde ofnunactpiroenvailolyuslryelpevuabnlitshdeidmseorlusttirounctNuMre,R bstarsuecdtuoren oaf mporenvoimouesrliyc mTSPO [29] in complex with its high affinity ligand 1-(2-chlorophenyl)-N-methyl-N-(1-. 2018, 19, 2588 published solution NMR structure of monomeric mTSPO [29] in complex with its high affinity ligand 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) (Kd = 2.1–28 nM, see Figure S1) [7,30,31] (mTSPO_NMR_monomer in this study, PDBiD: 2MGY). Sci. 2018, 19, 2588 published solution NMR structure of monomeric mTSPO [29] in complex with its high affinity ligand 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) (Kd = 2.1–28 nM, see Figure S1) [7,30,31] (mTSPO_NMR_monomer in this study, PDBiD: 2MGY) This model [20] shows some inconsistencies. Our prediction turns out to be fully consistent with the available experimental topological information, delving for the first time into the structural determinants of this exceptionally important target for pharmacological interventions and diagnostics

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.